Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector
- PMID: 10095100
- DOI: 10.1016/s0378-1119(99)00045-1
Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector
Abstract
The tetracycline-responsive expression system is based on the ability of the chimeric tTA and rtTA transactivators to stimulate specifically transcription from a companion synthetic CMV* or TK* promoter element, and can provide tightly regulated gene expression that can be induced up to five orders of magnitude in cultured cells and transgenic mice. A major problem with the system is that high level expression of the tTA or rtTA transactivators causes cellular toxicity. Under conditions of prolonged expression this results in selective pressure against the stable incorporation of vectors expressing the tTA or rtTA transactivators, and makes the generation of stable cell lines and transgenic mice problematic. In this report we describe the development of a set of autoregulated bi-directional expression vectors in which the weaker TK* promoter is used to direct expression of the rtTA or tTA transactivator and the stronger CMV* element is used to direct cDNA expression. In this format the transactivator and response elements are encoded on the same vector, which simplifies the system and ensures that gene expression is effectively skewed in favor of the cDNA while maintaining a continuously low level of transactivator expression. We find that such an autoregulated system works equally well for both the tTA and rtTA transactivators, provided that they contain a nuclear localization signal. Similar to other versions of the tetracycline-responsive expression system, gene expression is tightly regulated and can be efficiently switched between the off and on expression states by doxycycline. In contrast with other tetracycline-responsive systems, however, expression of the rtTA and tTA transactivators from the autoregulated TK* promoter is low enough such that there is no cellular toxicity associated with either expression state. By incorporating a selectable marker into these vectors, all of the components required for using the system are now contained on a single plasmid construct, and we find that this format provides a more reliable and greatly simplified method for the generation of stable cell lines.
Similar articles
-
Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors.Gene. 2004 Feb 18;327(1):61-73. doi: 10.1016/j.gene.2003.10.029. Gene. 2004. PMID: 14960361
-
A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells.J Gene Med. 1999 Jan-Feb;1(1):4-12. doi: 10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO;2-Y. J Gene Med. 1999. PMID: 10738580
-
Use of a recombinant parvovirus to facilitate screening for human melanoma cell clones expressing tetracycline-responsive transactivators.Gene. 1999 Mar 18;229(1-2):125-9. doi: 10.1016/s0378-1119(99)00034-7. Gene. 1999. PMID: 10336332
-
Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling.Semin Cell Dev Biol. 2002 Apr;13(2):121-8. doi: 10.1016/s1084-9521(02)00018-6. Semin Cell Dev Biol. 2002. PMID: 12127145 Review.
-
Optimizing regulatable gene expression using adenoviral vectors.Exp Physiol. 2005 Jan;90(1):33-7. doi: 10.1113/expphysiol.2004.028209. Epub 2004 Nov 12. Exp Physiol. 2005. PMID: 15542617 Review.
Cited by
-
PTEN inhibits adrenomedullin expression and function in brain tumor cells.J Neurooncol. 2006 Sep;79(2):117-23. doi: 10.1007/s11060-005-9035-7. Epub 2006 Jul 5. J Neurooncol. 2006. PMID: 16821090
-
Regulatable gene expression systems for gene therapy.Curr Gene Ther. 2006 Aug;6(4):421-38. doi: 10.2174/156652306777934829. Curr Gene Ther. 2006. PMID: 16918333 Review.
-
Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease.Mol Ther. 2009 Dec;17(12):2031-40. doi: 10.1038/mt.2009.174. Epub 2009 Jul 28. Mol Ther. 2009. PMID: 19638957 Free PMC article.
-
Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells.Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5124-9. doi: 10.1073/pnas.0530097100. Epub 2003 Apr 16. Proc Natl Acad Sci U S A. 2003. PMID: 12700349 Free PMC article.
-
Stringent and reproducible tetracycline-regulated transgene expression by site-specific insertion at chromosomal loci with pre-characterised induction characteristics.BMC Mol Biol. 2007 May 10;8:30. doi: 10.1186/1471-2199-8-30. BMC Mol Biol. 2007. PMID: 17493262 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources